Sofosbuvir and Velpatasvir, 400 mg/100 mg tablets, 28 tablets: 2x14 blister cards, Rx Only, Manuf...

FDA Recall #D-0313-2025 — Class II — March 7, 2025

Recall #D-0313-2025 Date: March 7, 2025 Classification: Class II Status: Ongoing

Product Description

Sofosbuvir and Velpatasvir, 400 mg/100 mg tablets, 28 tablets: 2x14 blister cards, Rx Only, Manufactured for: Asegua Therapeutics LLC an affiliate of Gilead Sciences, Inc., Foster City, CA 94404, Made in Ireland, NDC# 72626-2701-1

Reason for Recall

Defective Container: blister packs not properly sealed resulting in tablets being loose in the carton.

Recalling Firm

ASEGUA THERAPEUTICS LLC — Foster City, CA

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

18,541 cartons.

Distribution

US Nationwide

Code Information

Lot# 24ASV002UA, Exp Date: 6/30/2028

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated